Translator Disclaimer
1 September 2012 Cross-Protection Against Fowl Cholera Disease with the Use of Recombinant Pasteurella multocida FHAB2 Peptides Vaccine
Author Affiliations +
Abstract

It has been demonstrated that fhaB2 (filamentous hemagglutinin) is an important virulence factor for Pasteurella multocida in development of fowl cholera disease and that vaccination with recombinant FHAB2 peptides derived from P. multocida, P-1059 (serotype A:3) protects turkeys against P-1059 challenge. Here the hypothesis that vaccination with the same rFHAB2 peptides could cross-protect turkeys against challenge with P. multocida χ73 (serotype A:1) was examined. Three rFHAB2 peptides were purified and pooled, and two doses, consisting of equal amounts of each, were administered subcutaneously to turkeys at 2-wk intervals. Simultaneously, control birds were administered sham inoculations. One week later, vaccinates and controls were challenged intranasally with P-1059 or χ73. The results showed vaccination with rFHAB2 peptides significantly protected turkeys against lethal challenge from both P. multocida serotypes (P < 0.01). The high degree of FHAB2 conservation across serotypes likely allow the observed cross-protection.

American Association of Avian Pathologists
Fred M. Tatum, Louisa B. Tabatabai, and Robert E. Briggs "Cross-Protection Against Fowl Cholera Disease with the Use of Recombinant Pasteurella multocida FHAB2 Peptides Vaccine," Avian Diseases 56(3), 589-591, (1 September 2012). https://doi.org/10.1637/9991-111611-ResNote.1
Received: 17 November 2011; Accepted: 1 April 2012; Published: 1 September 2012
JOURNAL ARTICLE
3 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top